# Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy

> **NCT05412706** · PHASE2 · WITHDRAWN · sponsor: **Ospedale Policlinico San Martino**

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Niraparib

## Key facts

- **NCT ID:** NCT05412706
- **Lead sponsor:** Ospedale Policlinico San Martino
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-09-04
- **Primary completion:** 2023-09-04
- **Final completion:** 2023-09-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The Principal Investigator has retired and has not been replaced has retired and a new one has not been identified Principal Investigator
- **Last updated:** 2023-09-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05412706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05412706, "Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05412706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*